Cargando…
Emerging Systemic Treatments for Atopic Dermatitis
Atopic dermatitis (AD) is a chronic or chronically relapsing inflammatory skin disease which results from a complex, multifaceted interaction between environmental factors in genetically predisposed patients. Epidermal barrier impairment, alteration of the cutaneous microbiota, effect of external an...
Autores principales: | Ferrucci, Silvia Mariel, Tavecchio, Simona, Marzano, Angelo Valerio, Buffon, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149421/ https://www.ncbi.nlm.nih.gov/pubmed/37072648 http://dx.doi.org/10.1007/s13555-023-00920-4 |
Ejemplares similares
-
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023) -
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients
por: Tavecchio, Simona, et al.
Publicado: (2020) -
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis
por: Ferrucci, Silvia, et al.
Publicado: (2021) -
Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
por: Ferrucci, Silvia, et al.
Publicado: (2023) -
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
por: FERRUCCI, Silvia Mariel, et al.
Publicado: (2021)